The National Quality Forum has appointed Helen Darling interim president and CEO.
Here are seven things to know about Ms. Darling.
1. She will begin her new role in March.
2. Her appointment follows the announcement that Christine Cassel, MD, will leave her post to join the leadership team designing the new Kaiser Permanente School of Medicine in Southern California.
3. Ms. Darling is the former president and CEO of the National Business Group on Health, a national nonprofit membership organization.
4. Ms. Darling led NQF's board for four years, and has been involved with numerous NQF projects over the years.
5. Most recently, she was as a member of the Intended Use Committee, which evaluated whether the use of a measure should be considered in the endorsement process. She also is a member of the Incubator Advisory Council, which governs NQF's Measure Incubator.
6. Outside of NQF, Ms. Darling is on the Committee on Performance Measurement of the National Committee for Quality Assurance, the Medical Advisory Panel of the Blue Cross Blue Shield Association's Technology Evaluation Center (now the Center for Clinical Effectiveness), and the advisory board for the Peter G. Peterson Foundation. She also serves on the Board of the Reagan Udall Foundation for the FDA.
7. Previously, she directed purchasing of health and disability benefits at Xerox Corp. and was a health benefits consultant at Mercer and Towers Watson.
More articles on healthcare executive moves:
Dr. Frank Vozos tapped as executive VP at Barnabas Health: 5 things to know
Beaufort Memorial CEO to leave position this year: 5 things to know
WPC Healthcare names director of business development: 3 things to know